Ledger.Open graph →
SEC Form D · filed November 26, 2024

Cyclacel Pharmaceuticals, Inc

Offering
$2.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY HEIGHTS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Duylinh Vu · Berkeley Heights, NJExec · DirectorSpiro Rombotis · Berkeley Heights, NJExec · DirectorRobert Spiegel · Berkeley Heights, NJDirectorKarin L. Walker · Berkeley Heights, NJDirectorChristopher S. Henney · Berkeley Heights, NJDirectorSamuel L. Barker · Berkeley Heights, NJDirectorBrian L. Schwartz · Berkeley Heights, NJDirectorPaul Mcbarron · Berkeley Heights, NJExec · DirectorKenneth Ferguson · Berkeley Heights, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗